Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs Anti-adhesion Gel for Intrauterine Adhesions
NCT05257213Recruiting
- Sponsor
- Nadezhda Women's Health Hospital
- Start
- Feb 2022
- Primary completion
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of heparin in Intrauterine Adhesions (IUA) (2 arms), sponsored by Nadezhda Women's Health Hospital. Primary endpoints: Number of patients with post-operative intrauterine adhesion formation, Number of patients with need for subsequent operative hysterectomy and 1 more. Started Feb 2022; status: recruiting.
02
Drugs
heparin
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT05257213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05257213.